• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MEDTRONIC HALL PROSTHETIC HEART VALVE; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MEDTRONIC HALL PROSTHETIC HEART VALVE; HEART-VALVE, MECHANICAL Back to Search Results
Model Number A7700
Device Problems Gradient Increase (1270); Obstruction of Flow (2423)
Patient Problems Corneal Pannus (1447); Aortic Regurgitation (1716); Stroke/CVA (1770); Endocarditis (1834); Blood Loss (2597); Thromboembolism (2654)
Event Date 02/01/2011
Event Type  Injury  
Manufacturer Narrative
Citation: cho yh et al.Serial changes of hemodynamic performance with medtronic hall valve in aortic position.Ann thorac surg.2011 feb;91(2):424-31.Doi: 10.1016/j.Athoracsur.2010.10.039.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature review regarding the long-term hemodynamic performance after the implant of a medtronic mechanical aortic valve.All data were collected from a single center between august 1997 and january 2004.The study population included 117 patients, 55 of which were implanted with an aortic valve and 62 which were implanted with both an aortic valve and a mitral valve.Serial numbers were not provided.The study population was predominantly female; mean age 51.2 ± 10.4 years.Among all patients adverse events included: increased gradient measurements, pannus (with and without leaflet interference) and subsequent stenosis, thromboembolism, hemorrhage, re-operation, cerebral vascular accident (cva), pneumonia, valve obstruction, regurgitation, endocarditis (haemophilus influenza) and coronary artery thrombus.Based on the available information, these events may have been attributed to a medtronic product.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC HALL PROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8220556
MDR Text Key132200945
Report Number2025587-2019-00071
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P790018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 01/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberA7700
Device Catalogue NumberA7700
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/10/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
-
-